Researchers identify new genetic risk factors and drug targets for rare bile duct disease

Scientists have uncovered previously unknown genetic vulnerabilities linked to primary sclerosing cholangitis, a rare autoimmune liver condition, and pinpointed candidate drugs that could be repurposed to treat it. The findings could accelerate drug development for a disease with no cure and limited treatment options.

Originaltitel: Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis